Status:
COMPLETED
Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI
Lead Sponsor:
Medical University of Lodz
Conditions:
Remote Ischemic Preconditioning
Contrast Induced - Acute Kidney Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prospective, randomized, sham-controlled clinical study was conducted to assess whether RIPC reduces the incidence of CI-AKI measured standard way of using SCr concentration but also with the use of s...
Detailed Description
Nowadays CI-AKI is defined according to serum creatinine concentration (SCr) as any of the following: (1) an absolute rise of ≥ 0.5 mg/dL (44 µmol/L) and/or (2) a relative increase of 25% in serum cre...
Eligibility Criteria
Inclusion
- aged over 18 years
- patients with stable angina pectoris
- patients admitted to Intensive Cardiac Therapy Clinic Medical University of Lodz with intention of elective CA with follow-up PCI.
Exclusion
- history of severe injuries up to 2 months before intervention
- history of surgeries up to 2 months before intervention
- history of cancer,
- acute inflammation during hospitalization
- chronic autoimmunologic diseases
- patients needing hemodialysis
- chronic kidney disease in stage 4 or 5 (eGFR\<30 ml/min/1,73m2)
- peripheral vascular disease affecting upper limbs.
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT03761368
Start Date
March 1 2015
End Date
June 30 2018
Last Update
November 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Cardiac Therapy Clinic
Lodz, Poland, 92-213